A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Healthy Volunteers
Interventions
DRUG

INFS (Intranasal Fentanyl Spray)

Intranasal Fentanyl Spray

Trial Locations (1)

68157

Nycomed Investigational Site, Mannheim

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY